mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.07 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.07 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.083 |
0.07 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |